Infographic: Changes to BsUFA Under FDARA

The Food and Drug Reauthorization Act of 2017, recently passed by the House, reauthorizes the Biosimilar User Fee Act (BsUFA). Learn about changes to the BsUFA in its new iteration, BsUFA II.

The Food and Drug Reauthorization Act of 2017, recently passed by the House, reauthorizes the Biosimilar User Fee Act (BsUFA). Learn more about changes to the BsUFA in its new iteration, BsUFA II.

Related Content:

PolicyRegulatory
BioRationality: A Proposal to Create a New Association With Rational Scientific Agenda
Can Global Policies to Boost Biosimilar Adoption Work in the US?
Breaking Down Biosimilar Barriers: Interchangeability